Galderma GALD.SW at CHF151.40 on SIX 11 Mar 2026: heavy intraday volume highlights trader interest

GALD.SW stock trades at CHF151.40 on the SIX intraday tape, down 2.89% from yesterday with volume 35,112,633, making it one of the market’s most active names today. The move follows a wide intraday range with a day low CHF149.80 and day high CHF155.10. Traders are watching liquidity and momentum after the share price slipped below the 50-day average CHF153.01 but remains above the 200-day average CHF141.02.

Intraday price action and volume for GALD.SW stock

GALD.SW stock opened at CHF153.00 and last traded CHF151.40, a CHF4.50 decline from the previous close CHF155.90. The stock’s intraday volume of 35,112,633 shares far exceeds the average volume 386,999, putting Galderma among the most active SIX names.

High volume with a negative delta signals distribution pressure for the session. Day range and large turnover make intraday support at CHF149.80 and resistance at CHF155.10 key levels for short-term traders.

Fundamentals and valuation snapshot for Galderma Group N (GALD.SW)

Galderma Group N is listed on the SIX in Switzerland and has market capitalization CHF36.30B with 234,823,853 shares outstanding. Trailing metrics show EPS CHF1.23 and a reported P/E (TTM) 32.65. Book value per share is CHF52.96 and P/B is 2.92.

Key ratios: EV/EBITDA 26.43, net debt/EBITDA 1.63, current ratio 1.09, ROE 8.91%, and dividend per share CHF0.15. These figures show growth with moderate leverage and a premium valuation versus many peers in Household & Personal Products.

Technical indicators and trend signals for GALD.SW

Technicals show a mixed momentum picture: RSI 56.38 suggests neutral strength while MACD histogram turned positive at 1.16. Bollinger middle band sits at CHF150.50, with upper CHF159.09 and lower CHF141.90.

Short-term trends: price sits near the 50-day moving average CHF153.01 and above the 200-day average CHF141.02. Average true range CHF5.39 signals elevated intraday volatility. Traders should watch RSI and the CHF150.50 middle band for intraday bias changes.

Meyka AI grade and GALD.SW stock analysis

Meyka AI rates GALD.SW with a score out of 100: 75.17 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

We note the model balances strong revenue per share CHF46.33 and cash flow per share CHF5.63 with a premium valuation. Meyka AI’s grade is informational and not investment advice.

Market drivers, upcoming catalysts and risks for GALD.SW

Drivers include continued strength in Injectable Aesthetics and Dermatological Skincare and reported FY growth: revenue growth 21.05% year-over-year. Upcoming earnings date is 23 Jul 2026, which could reset expectations.

Risks: premium valuation, exposure to cosmetic discretionary spending cycles, and concentrated intangible assets (intangibles/total assets 76.72%). Watch macro consumer trends in Switzerland and Europe for demand sensitivity.

Trading outlook and price targets for traders and investors

Short-term traders should monitor intraday support CHF149.80 and resistance CHF155.10. A break below CHF149.80 could test the 200-day average CHF141.02. Upside near-term target: CHF165.00 based on the quarter forecast and liquidity levels.

Longer-term price guidance uses Meyka model projections (see conclusion). Use position sizing given ATR CHF5.39 and elevated turnover. Sources: company site and corporate social feed for updates Galderma and Galderma Twitter.

Final Thoughts

Key takeaways: GALD.SW stock trades at CHF151.40 on the SIX intraday session with heavy volume 35,112,633, making it one of the market’s most active names today. Valuation is premium with P/E (TTM) 32.65 and P/B 2.92, while operating cash flow per share is CHF5.63. Meyka AI’s forecast model projects a yearly price CHF206.65, implying an upside of 36.50% versus the current CHF151.40. The model also shows a monthly projection CHF132.76 (downside -12.31%) and a quarterly projection CHF165.79 (upside 9.50%). Forecasts are model-based projections and not guarantees. Traders should balance the potential upside with premium valuation and upcoming earnings on 23 Jul 2026. For intraday traders, watch the near-term pivot band around CHF150.50 and manage risk with stop levels sized to ATR CHF5.39. Meyka AI provides this AI-powered market analysis for context; perform your own due diligence before acting.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.